Literature DB >> 8142240

Prompt remission of post-renal transplant nephrotic syndrome with high-dose cyclosporine.

R N Srivastava1, A Kalia, L B Travis, S C Diven, K K Gugliuzza, S Rajaraman.   

Abstract

A 2.8-year-old girl with focal segmental glomerulosclerosis had recurrence of nephrotic syndrome within 3 days of renal transplantation and the serum creatinine increased. Renal biopsy showed cellular rejection and also complete effacement of the epithelial cell foot processes. The rejection responded to methylprednisolone therapy but massive proteinuria persisted. An increase in the dose of cyclosporine A to 14 mg/kg per day was followed by immediate remission of the proteinuria. One month later, a second renal biopsy showed only focal fusion of foot processes. She remains free of proteinuria 2 years later. We propose that the higher dose of cyclosporine caused remission of the nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142240     DOI: 10.1007/bf00868281

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation.

Authors:  E Ingulli; A Tejani; K M Butt; D Rajpoot; R Gonzalez; A Pomrantz; R Ettenger
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

2.  Ciclosporin-induced partial and transient improvement of nephrotic syndrome in recurrent focal segmental glomerulosclerosis.

Authors:  J M Morales; A Andres; C Prieto; M Praga; V Gutierrez Millet; J L Rodicio
Journal:  Nephron       Date:  1989       Impact factor: 2.847

3.  Recurrence of focal segmental sclerosis in children following renal transplantation.

Authors:  J E Striegel; R K Sibley; D S Fryd; S M Mauer
Journal:  Kidney Int Suppl       Date:  1986-07       Impact factor: 10.545

4.  Recurrent focal segmental glomerulosclerosis. A pathological study of the early lesion.

Authors:  R R Verani; E P Hawkins
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

5.  Recurrent focal glomerulosclerosis: natural history and response to therapy.

Authors:  M Artero; C Biava; W Amend; S Tomlanovich; F Vincenti
Journal:  Am J Med       Date:  1992-04       Impact factor: 4.965

6.  Plasma exchange for recurrent nephrotic syndrome following renal transplantation.

Authors:  J Laufer; R B Ettenger; W G Ho; A H Cohen; J L Marik; R N Fine
Journal:  Transplantation       Date:  1988-10       Impact factor: 4.939

7.  Cyclosporine, low-density lipoprotein, and cholesterol.

Authors:  P C de Groen
Journal:  Mayo Clin Proc       Date:  1988-10       Impact factor: 7.616

8.  Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.

Authors:  V E Torres; J A Velosa; K E Holley; P P Frohnert; H Zincke; S Sterioff
Journal:  Mayo Clin Proc       Date:  1984-03       Impact factor: 7.616

Review 9.  Recurrent primary disease and de novo nephritis following renal transplantation.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

10.  Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience.

Authors:  E Ingulli; A Tejani
Journal:  Transplantation       Date:  1991-02       Impact factor: 4.939

  10 in total
  1 in total

1.  Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome.

Authors:  Kandai Nozu; Kazumoto Iijima; Masato Fujisawa; Atsuko Nakagawa; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.